Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Breast Neoplasms 5Leukemia, Myeloid, Acute 4Leukemia 2Triple Negative Breast Neoplasms 1Thrombocythemia, Essential 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1HER2-negative Breast Cancer 1Breast Cancer Early Stage Breast Cancer (Stage 1-3) 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 34Busulfan 32fludarabine phosphate 29Cyclosporine 24Mycophenolic Acid 22Peripheral Blood Stem Cell Transplantation 21Whole-Body Irradiation 19Antilymphocyte Serum 19Tacrolimus 15Methotrexate 15Cytarabine 15fludarabine 14Melphalan 14Cord Blood Stem Cell Transplantation 14Radiotherapy 13Filgrastim 12Methylprednisolone 9Granulocyte Colony-Stimulating Factor 9Etoposide 7Thiotepa 6thymoglobulin 5sargramostim 5Idarubicin 5Cyclosporins 5Clofarabine 5Azacitidine 5merphos 4Gemtuzumab 4Decitabine 4Arsenic Trioxide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Anemia, Refractory, with Excess of Blasts × Anthracyclines × Clear all
NCT02084563 2016-11-08

Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms

Hospital Israelita Albert Einstein

Phase 2 Completed
455 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡